Emerging Systemic Treatments for Atopic Dermatitis.

Dermatol Ther (Heidelb) · 2023 · PMC10149421 · PMID 37072648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The number of patients who achieved EASI-50, when compared with placebo, was higher in the 4-mg baricitinib group ( P = 0.027) and in the 2-mg baricitinib, even though the latter did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.